Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis
January 2018
in “Acta dermato-venereologica”
TLDR Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.
A systematic review and meta-analysis of 15 trials with 4,495 male patients found that the use of finasteride or dutasteride to treat androgenetic alopecia increased the risk of sexual dysfunction by 1.57 times. The study recommends that physicians should be aware of this risk and assess the possibility of sexual dysfunction in patients treated with these drugs. The adverse sexual effects of these drugs include decreased libido, erectile dysfunction, and ejaculation disorders. Patients should be informed of these potential side effects before starting treatment.
View this study on medicaljournals.se →
Related
research The clinical applications of five-alpha reductase inhibitors.
Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.
research Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor
Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.